Selfie AI empowers healthcare providers to eradicate preventable vision loss—transforming any smartphone into a clinical-grade retinal scanner. By seamlessly combining an ultra-affordable fundus lens with our lightning-fast, on-device AI engine. Primary care centers now can screen for diabetic retinopathy in under 60 seconds—completely offline and without the need for specialists.
Revolutionary AI-powered retinal screening that makes diabetic retinopathy detection fast, affordable, and accessible anywhere.
Sub-60-second inference with ≥ 90% sensitivity for early-stage diabetic retinopathy detection.
Works on any iOS/Android device; no bulky equipment or specialist training needed.
Just USD 3 per scan, making mass screening in low-resource regions feasible.
On-device AI keeps patient data local and workflows uninterrupted—even in remote clinics.
Health worker launches Selfie AI and snaps a fundus photo
AI evaluates image quality and runs diabetic retinopathy detection in < 60s
Risk score displayed on-screen; "urgent referral" flags trigger automated alerts
Data auto-uploads when online; administrators access full program analytics
Screen 5× more patients per day without hiring additional ophthalmologists.
Focus high-risk patients on advanced care; automate routine follow-ups.
Publish screening outcomes and population health metrics in real time.
Patient data encrypted on-device; HIPAA- and GDPR-ready.

Our modular AI platform is roadmap-ready to detect multiple conditions from a single smartphone scan.
Via retinal vasculature analysis
From micro-aneurysm patterns
Through neuro-retinal biomarkers
Each new AI module unlocks additional revenue per scan and deepens clinical insights—all with the same smartphone scan.




Empower your network with fast, affordable, AI-powered retinal screening.